Literature DB >> 28987047

[Epidemiology and risk factors of hepatocellular carcinoma].

Agnieszka Budny1, Piotr Kozłowski1, Marzena Kamińska2, Małgorzata Jankiewicz2, Agnieszka Kolak3, Bożena Budny2, Witold Budny2, Joanna Niemunis-Sawicka4, Grzegorz Szczypiór5, Bartosz Kurniawka6, Franciszek Burdan1.   

Abstract

Primary liver neoplasms occurs relatively rarely in Poland. The most frequently occurring type of cancer is hepatocellular carcinoma (HCC), which globally constitutes 7% of all the occurrences of cancer. The incidence increases with age and is the highest in patients around the age of 70. It also varies significantly depending on the geographic location. The main factors that cause HCC are infection of HBV and HCV, whose genome integrates into the DNA of the host, causing mutations. The other factors include excessive alcohol consumption, contact or consumption of Aspergillus toxins as well as various metabolic disorders, such as α1-antitrypsin deficiency, hemochromatosis, tyrosinemia, porphyria, von Gierke disease and in person with gene mutation p.I148M of adiponutrin. HCC is usually detected incidentally, during ultrasound examination or during clinical diagnosis of liver failure. HCC can be diagnosed using computed tomography (CT) or magnetic resonance imaging (MRI), which is considered the most accurate diagnostic method. A core needle biopsy or the examination of the level of markers such as: alpha-fetoprotein (AFP), D-gamma-carboxy prothrombin (DCP), tumourassociated glycoprotein 72 (CA 72-4, TAG-72), are advised for a complete diagnostics.

Entities:  

Keywords:  epidemiology; hepatocellular carcinoma; risk factors

Mesh:

Year:  2017        PMID: 28987047

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  26 in total

Review 1.  The Emerging Role of EVA1A in Different Types of Cancers.

Authors:  Huijie Zhao; Huiyang Liu; Yihan Yang; Honggang Wang
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

2.  Evaluating Radioactive Analogs of Doxorubicin to Quantify ChemoFilter Binding and Whole-Body Positron Emission Tomography/Magnetic Resonance Imaging for Drug Biodistribution.

Authors:  Parth Kumar; Colin Yee; Joseph E Blecha; Thomas R Hayes; Bridget F Kilbride; Carol Stillson; Aaron D Losey; Eric Mastria; Caroline D Jordan; Tony L Huynh; Terilyn Moore; Mark W Wilson; Henry F VanBrocklin; Steven W Hetts
Journal:  J Vasc Interv Radiol       Date:  2022-03-15       Impact factor: 3.682

3.  Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis.

Authors:  Haohao Lu; Chuansheng Zheng; Bin Liang; Bin Xiong
Journal:  BMC Cancer       Date:  2021-05-07       Impact factor: 4.430

4.  The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection.

Authors:  Guojin Ou; Haixia Xu; Hao Yu; Xiao Liu; Liu Yang; Xin Ji; Jue Wang; Zhong Liu
Journal:  J Transl Med       Date:  2018-12-18       Impact factor: 5.531

5.  The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis.

Authors:  Ming-Li Yang; Zhe Huang; Qian Wang; Huan-Huan Chen; Sai-Nan Ma; Rong Wu; Wei-Song Cai
Journal:  Biosci Rep       Date:  2018-09-05       Impact factor: 3.840

6.  Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

Authors:  Müfide Okay; Sıla Çetik; İbrahim C. Haznedaroğlu
Journal:  Turk J Haematol       Date:  2019-05-09       Impact factor: 1.831

7.  Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.

Authors:  Anıl Çolaklar; Namık Kemal Altınbaş
Journal:  J Ultrason       Date:  2020-03-31

8.  EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.

Authors:  Jia Wang; Yanlin Zhong; Guixia Meng
Journal:  Int J Clin Oncol       Date:  2021-07-21       Impact factor: 3.402

9.  Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis.

Authors:  Haohao Lu; Chuansheng Zheng; Bin Liang; Bin Xiong
Journal:  BMC Gastroenterol       Date:  2021-06-11       Impact factor: 3.067

10.  Effect of sodium cantharidinate/vitamin B6 injection on survival, liver function, immune function, and quality of life in patients with hepatocellular carcinoma: Protocol for a meta-analysis.

Authors:  Min Zhu; Xiujing Liu; Changhui Zhou; Juan Li
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.